Background: Adults aging with HIV are at greater risk for several comorbidities. The CD4 + cell count and CD4 + /CD8 + ratio often fail to normalize in elderly patients despite prolonged antiretroviral therapy; this has been associated with concomitant diseases and poor prognosis.
INTRODUCTION
The introduction of combination antiretroviral treatment (cART) profoundly changed the life expectancy of HIVpositive patients. By transforming a deadly infection into a chronic disease, the number of elderly patients increased significantly: models estimate that the proportion of patients aged 60 years or older will increase from 8% to 39% in 2030. 1 Aging with HIV is seldom healthy and patients have to face the inevitable passage of time with additional burdens. [2] [3] [4] HIV-infected patients age with several years of immune deficiency, chronic inflammation, coinfections, and drugassociated toxicities: the longer the infection the higher the prevalence of comorbid conditions. The aging immune system faces several changes (including the reduction in CD4 T-cell reserves, in naive T cell and telomere shortening) that eventually lead to immune senescence and low grade inflammation (the so-called inflammaging). 5, 6 In HIVuninfected subjects, the ratio between CD4 + and CD8 + T lymphocytes (CD4 + /CD8 + ratio) represents a marker of T-cell function and an "inverted" value (,1) has been identified as a predictor of unfavorable outcomes in elderly individuals. 7 In 85%-90% of virologically suppressed cART-treated patients, the CD4 + /CD8 + ratio fails to normalize: low nadir CD4 + cell counts and advanced age have been identified as risk factors for incomplete immunological recovery. 8 Several pieces of evidence confirm that a persistently low CD4 + /CD8 + ratio during effective cART is associated with increased innate and adaptive immune activation, an immunosenescent phenotype and higher risk of morbidity/mortality in this group of individuals. 9, 10 The aim of this study was to describe the predictors of normalized T-cell subsets ("nT" ie, CD4 + /CD8 + ratio $ 1 and CD4 + cell count $ 500/mL) and its association with HIV-associated non-AIDS conditions (HANA) in a cohort of HIV-positive patients above the age of 65.
METHODS
The GEriatric Patients living with HIV/AIDS: a Prospective Multidimensional cOhort (GEPPO) is a multicentric ongoing study in HIV-positive geriatric patients (65 years and older) enrolled in 10 Italian institutions. This study is a crosssectional analysis of the entire GEPPO cohort (n = 1679) at initial visit (performed between June 2015 and May 2016) including patients with available CD4 + and CD8 + T-cell count. Inclusion criteria were age older than 65 years, confirmed HIV-positivity, being on cART for at least 6 months. Ethics Committee approval was obtained from Research Ethics Board of each individual center belonging to the GEPPO cohort. All participants provided written consent at their initial clinical visit.
Study endpoints were the prevalence and the predictors of nT; secondary endpoint was the association of nT with comorbidities, multimorbidity (MM), and polypharmacy (PP). MM was defined as the presence of 3 or more HANAs, whereas PP as the regular consumption of 5 or more drugs beyond antiretrovirals as previously described. 10 Duration of HIV infection was calculated as the time between HIV diagnosis and last study visit. This variable was stratified into ,10, 10-20, and .20 years duration groups. Laboratory results were included if within 6 months of the study visit.
Data are expressed as number (prevalence) or average (6standard deviation). Multivariate binary logistic regression was used for obtaining age and gender-adjusted associations between nT and HANA conditions. Stepwise multivariate binary logistic regression models were tested using clinically relevant and significant variable at bivariate parametric analysis (P , 0.10).
RESULTS
A total of 1092 patients were included: their clinical and epidemiological features are described in Table 1 (and  stratified by sex in Supplemental Digital Content Table, http://links.lww.com/QAI/B63). Their median age was 71.3 years (64.9, range 65-91). nT was observed in 340 patients (31.1%): patients not presenting nT (nnT) were more likely to be men (P = 0.01), with lower nadir and current CD4 + cell counts, higher CD8 + cell count and not virologically suppressed. No other statistically significant difference emerged between the 2 groups. No association between the number of antiretroviral drugs (triple vs. dual vs. mono therapies) or the features of third drugs [protease inhibitors vs. nonnucleoside reverse transcriptase inhibitors vs. integrase strand transfer inhibitors] and the prevalence of nT was observed. When we stratified patients for HIV duration, we observed that 305 subjects (28.3%) were infected for . The prevalence of specific HANA conditions, MM and PP is described in (Table 1) . When stratified for HIV duration, the prevalence of HANA conditions was higher in patients with more than 20 years of infection: such a difference was statistically significant for bone disease (39.8% vs. 27.6% vs. 2.6%, P = 0.001), cardiovascular disease (25.7% vs. 18% vs. 16.7%, P = 0.048), lipid abnormalities (74.6% vs. 74.4% vs. 59.8%, P , 0.001), diabetes (39.9% vs. 28.2% vs. 20%, P , 0.001), cirrhosis (11.7% vs. 4.5% vs. 1%, P , 0.001), COPD (11.1% vs. 4.6% vs. 6.4%, P = 0.015), and MM (65.3% vs. 48.6% vs. 34.2%, P , 0.001).
To explore whether nT was associated with HANA conditions or MM independently of HIV duration bivariate ( Fig. 1) and multivariate binary logistic regression analysis were performed. After correcting for age, sex, body mass index and nT, HIV duration was an independent predictor of chronic kidney impairment, bone disease, lipid abnormalities, hypertension, diabetes, and cirrhosis. nT was independently protective for cancer and COPD. HIV duration and nT were simultaneous predictors of MM.
DISCUSSION
We observed that approximately one-third (31.1%) of geriatric HIV-positive patients obtained normalized T-cell subsets; female sex, a higher pre-cART CD4 + cell count and control of plasma viral load were associated with such immunological goal. nT prevalence was not different from what observed in other studies where it ranged from 19% to 26% in younger subjects; using a 0.7 threshold this further increased to 37%. 8, 11 Although CD4 + cell count nadir has been linked to nT in almost all studies, other predictors have been variably associated, such as treatment with nonnucleoside reverse transcriptase inhibitors, age, and negative cytomegalovirus IgG serological results. 12, 13 Men and women seem to suffer the same age-related changes in the immune system; however, men usually display a more rapid immune senescence and more commonly an inverted CD4 + / CD8 + ratio. 14, 15 In our analysis female subjects, despite being only 17.5% of the cohort, had a significantly higher prevalence of nT than men (39.3% vs. 29.4%; P = 0.010) and of normalized CD8 + cell percentage (73.3% vs. 60.6%, P = 0.001). Our initial hypothesis was that the age of HIV acquisition might be a determinant for insufficient T-cell normalization, as it is relevant for the prevalence of several comorbidities. 9 We observed no effect of longer HIV duration on the probability of reaching normalized T-cell subsets, though our results may be biased by a lower CD4 + cell count at nadir in the intermediate HIV duration range. The strongest predictor of an nT was the presence of controlled plasma HIV viral load. Persistent low-level viremia has been associated with microbial translocation and inflammation. 16 Furthermore, lifelong cumulative HIV viremia has been associated with the CD4 + /CD8 + ratio recovery in a cohort of patients followed after primary infection. Additionally persistent low-level viremia (measured as viremia copy-years) has been associated with a high risk of all-cause mortality in HIVinfected patients. 17, 18 These pieces of evidence highlight the need for optimal viral control (potentially including other chronic infections such as cytomegalovirus) to improve the function of a senescent immune system.
In this study, we also observed a very high prevalence of comorbidities; almost half of the included patients fulfilled the MM criteria. This is in line with the observed and projected data in HIV-positive subjects and shows a higher prevalence than in age-matched negative individuals. 1, 10 In younger HIV-positive subjects, the association of an inverted CD4 + /CD8 + ratio with several comorbidities has been reported. Nonetheless, data in elderly individuals are limited and affected by a relevant survival bias. In our study, we observed a significantly higher prevalence of MM, independently from traditional risk factors, in individuals with normalized T-cell subsets; these surprising results might be explained by several years of cART-associated toxicities (and confirmed by the higher prevalence in patients with longer HIV duration) and they may represent a survivor effect where other factors (including health conditions, body mass index, and genetics) have affected the outcome of major cardiovascular disorders. However, normalized T-cell subsets were protective for COPD and non-AIDS cancers independently from the duration of HIV infection and antiretroviral treatment. Both diseases, COPD and non-AIDS cancer, require immune vigilance and it seems reasonable that a normalized T-cell count might be associated with a lower prevalence of such conditions. Recent evidence confirms our results because low CD4/CD8 ratio has been associated with non-AIDS-defining cancers in patient on cART and a ratio ,0.5 could identify patients who require a more intensive strategy for cancer prevention and screening. 19 Other data, also, showed that HIV suppression normalizes peripheral and lung immunity in smokers thus reducing the risk of COPD. 20 The association between a normalized CD4 + /CD8 + ratio and a lower prevalence of comorbidities and cancers is still uncertain: the reduction in PD1 expression on CD8 + cells in patients with high CD4 + /CD8 + ratios may determine a better immunological effectiveness and an improved response to vaccines. 9, 21 We should acknowledge a few limitations of this study: the cross-sectional design, the lack of cytomegalovirus serology and titer, the lack of specific T-cell subpopulations. The single-point evaluation and the lack of blood pressure measurements in all patients warrant caution in interpreting the observed association with hypertension.
In conclusion, 31.1% of geriatric HIV-positive subjects have normalized T-cell subsets; higher CD4 + nadir, female sex, and plasma HIV RNA undetectability were independently associated with this endpoint. nT was independently associated with hypertension and protective for cancer and COPD. HANA conditions were more common in patients with more than 20 years of infection that represents an independent predictor of chronic kidney impairment, bone
